{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T14:31:20Z","timestamp":1781965880810,"version":"3.54.5"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hearing Research"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.heares.2025.109262","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T06:59:44Z","timestamp":1743749984000},"page":"109262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Drug-induced hearing loss: a real-world pharmacovigilance study using the FDA adverse event reporting system database"],"prefix":"10.1016","volume":"461","author":[{"given":"Tingxi","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5215-5942","authenticated-orcid":false,"given":"Dongxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heares.2025.109262_bib0001","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/14740338.2017.1323867","article-title":"Empirical estimation of under-reporting in the U.S. food and drug administration adverse event reporting system (Faers)","volume":"16","author":"Alatawi","year":"2017","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.heares.2025.109262_bib0002","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.3389\/fphar.2019.01161","article-title":"Ototoxic adverse drug reactions: a disproportionality analysis using the Italian spontaneous reporting database","volume":"10","author":"Barbieri","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heares.2025.109262_bib0003","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/MPG.0000000000002654","article-title":"Neurological adverse effects associated with anti-tumor necrosis factor alpha antibodies in pediatric inflammatory bowel diseases","volume":"70","author":"Bertrand","year":"2020","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.heares.2025.109262_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157753","article-title":"Openvigil Fda - inspection of U.S. American adverse drug events pharmacovigilance data and novel clinical applications","volume":"11","author":"Bohm","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.heares.2025.109262_bib0005","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2471\/BLT.21.285643","article-title":"The world report on hearing, 2021","volume":"99","author":"Chadha","year":"2021","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.heares.2025.109262_bib0006","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.heares.2010.02.010","article-title":"Too much of a good thing: long-term treatment with salicylate strengthens outer hair cell function but impairs auditory neural activity","volume":"265","author":"Chen","year":"2010","journal-title":"Hear. Res."},{"key":"10.1016\/j.heares.2025.109262_bib0007","first-page":"601","article-title":"Pharmacological drugs inducing ototoxicity, vestibular symptoms and tinnitus: a reasoned and updated guide","volume":"15","author":"Cianfrone","year":"2011","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.heares.2025.109262_bib0008","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.24373","article-title":"Low-Dose Aspirin and progression of age-related hearing loss: a secondary analysis of the aspree randomized clinical trial","volume":"7","author":"Clark","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.heares.2025.109262_bib0009","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0140-6736(21)00516-X","article-title":"Hearing loss prevalence and years lived with disability, 1990-2019: findings from the global burden of disease study 2019","volume":"397","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.heares.2025.109262_bib0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3109\/14992027.2015.1094188","article-title":"Ototoxicity (Cochleotoxicity) classifications: a review","volume":"55","author":"Crundwell","year":"2016","journal-title":"Int. J. Audiol."},{"key":"10.1016\/j.heares.2025.109262_bib0011","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.amjmed.2009.08.006","article-title":"Analgesic use and the risk of hearing loss in men","volume":"123","author":"Curhan","year":"2010","journal-title":"Am. J. Med."},{"key":"10.1016\/j.heares.2025.109262_bib0012","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/aje\/kws146","article-title":"Analgesic use and the risk of hearing loss in women","volume":"176","author":"Curhan","year":"2012","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.heares.2025.109262_bib0013","first-page":"820","article-title":"Association of outpatient oral macrolide use with sensorineural hearing loss in children, adolescents, and young adults","volume":"148","author":"Dabekaussen","year":"2022","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.heares.2025.109262_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2021.102117","article-title":"Ototoxic hearing loss from antimalarials: a systematic narrative review","volume":"43","author":"Dillard","year":"2021","journal-title":"Travel. Med. Infect. Dis."},{"key":"10.1016\/j.heares.2025.109262_bib0015","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.joto.2016.10.001","article-title":"Ototoxic effects and mechanisms of loop diuretics","volume":"11","author":"Ding","year":"2016","journal-title":"J Otol"},{"key":"10.1016\/j.heares.2025.109262_bib0016","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s40272-020-00425-z","article-title":"Drug-induced hearing loss in children: an analysis of spontaneous reports in the french pharmacovigilance database","volume":"23","author":"Gainville","year":"2021","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.heares.2025.109262_bib0017","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/B978-0-444-62630-1.00027-5","article-title":"Deafness in cochlear and auditory nerve disorders","volume":"129","author":"Hopkins","year":"2015","journal-title":"Handb. Clin. Neurol."},{"key":"10.1016\/j.heares.2025.109262_bib0018","doi-asserted-by":"crossref","first-page":"e566","DOI":"10.1097\/MAO.0000000000004260","article-title":"A biologic with otologic consequences: analysis of hearing loss and teprotumumab using the fda adverse event reporting system","volume":"45","author":"Huynh","year":"2024","journal-title":"Otol. Neurotol."},{"key":"10.1016\/j.heares.2025.109262_bib0019","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/lary.26799","article-title":"Macrolide-associated sensorineural hearing loss: a systematic review","volume":"128","author":"Ikeda","year":"2018","journal-title":"Laryngoscope"},{"key":"10.1016\/j.heares.2025.109262_bib0020","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.661740","article-title":"The ototoxicity of antimalarial drugs-a state of the art review","volume":"12","author":"Jozefowicz-Korczynska","year":"2021","journal-title":"Front. Neurol."},{"key":"10.1016\/j.heares.2025.109262_bib0021","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/jamia\/ocv153","article-title":"Openfda: an innovative platform providing access to a wealth of Fda's publicly available data","volume":"23","author":"Kass-Hout","year":"2016","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"10.1016\/j.heares.2025.109262_bib0022","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ophtha.2023.08.001","article-title":"Frequency and patterns of hearing dysfunction in patients treated with teprotumumab","volume":"131","author":"Keen","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/j.heares.2025.109262_bib0023","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/eva.13167","article-title":"Why women have more autoimmune diseases than men: an evolutionary perspective","volume":"14","author":"Kronzer","year":"2021","journal-title":"Evol. Appl."},{"key":"10.1016\/j.heares.2025.109262_bib0024","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/0194599814553930","article-title":"Ubiquitous aspirin: a systematic review of its impact on sensorineural hearing loss","volume":"152","author":"Kyle","year":"2015","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.heares.2025.109262_bib0025","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/cpt.603","article-title":"Drug-induced ototoxicity: mechanisms, pharmacogenetics, and protective strategies","volume":"101","author":"Lanvers-Kaminsky","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.heares.2025.109262_bib0026","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1093\/geront\/gnz009","article-title":"Hearing loss and depression in older adults: a systematic review and meta-analysis","volume":"60","author":"Lawrence","year":"2020","journal-title":"Gerontologist"},{"key":"10.1016\/j.heares.2025.109262_bib0027","article-title":"Detection of unknown ototoxic adverse drug reactions: an electronic healthcare record-based longitudinal nationwide cohort analysis","volume":"11","author":"Lee","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.heares.2025.109262_bib0028","doi-asserted-by":"crossref","first-page":"E52","DOI":"10.1503\/cmaj.140339","article-title":"Aminoglycoside-induced ototoxicity","volume":"187","author":"Leis","year":"2015","journal-title":"CMAJ"},{"key":"10.1016\/j.heares.2025.109262_bib0029","doi-asserted-by":"crossref","DOI":"10.1177\/20420986241274909","article-title":"Assessing the risk of tumor lysis syndrome associated with the use of antineoplastic agents: a real-world pharmacovigilance study based on the fda adverse event reporting system database","volume":"15","author":"Li","year":"2024","journal-title":"Ther. Adv. Drug. Saf."},{"key":"10.1016\/j.heares.2025.109262_bib0030","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.autrev.2018.01.014","article-title":"Hearing loss in autoimmune disorders: prevalence and therapeutic options","volume":"17","author":"Mancini","year":"2018","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.heares.2025.109262_bib0031","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1080\/14992027.2021.1883197","article-title":"Estimating the global costs of hearing loss","volume":"60","author":"Mcdaid","year":"2021","journal-title":"Int. J. Audiol."},{"key":"10.1016\/j.heares.2025.109262_bib0032","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1044\/2023_AJA-22-00157","article-title":"Is Methotrexate ototoxic? investigating the ototoxic late effects of pediatric cancer treatment","volume":"32","author":"Moore","year":"2023","journal-title":"Am. J. Audiol."},{"key":"10.1016\/j.heares.2025.109262_bib0033","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2165\/00002018-200730070-00009","article-title":"Standardised meddra queries: their role in signal detection","volume":"30","author":"Mozzicato","year":"2007","journal-title":"Drug Saf."},{"key":"10.1016\/j.heares.2025.109262_bib0034","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.jaip.2018.11.034","article-title":"Hearing loss and middle ear symptoms in aspirin-exacerbated respiratory disease","volume":"7","author":"Mullur","year":"2019","journal-title":"J. Allergy Clin. Immunol. Pract."},{"key":"10.1016\/j.heares.2025.109262_bib0035","article-title":"Hearing loss and cognitive decline: prioritizing equity in a world in which hearing health matters","volume":"10","author":"Nieman","year":"2024","journal-title":"Alzheimers Dement. (N Y)"},{"key":"10.1016\/j.heares.2025.109262_bib0036","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2024.1379743","article-title":"Ototoxicity: a high risk to auditory function that needs to be monitored in drug development","volume":"17","author":"Pasdelou","year":"2024","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.heares.2025.109262_bib0037","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1016\/S2214-109X(23)00514-4","article-title":"Priorities for hearing loss prevention and estimates of global cause-specific burdens of hearing loss: a systematic rapid review","volume":"12","author":"Prasad","year":"2024","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.heares.2025.109262_bib0038","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.therap.2023.10.011","article-title":"Drug-induced hearing loss: listening to the latest advances","volume":"79","author":"Reynard","year":"2024","journal-title":"Therapie"},{"key":"10.1016\/j.heares.2025.109262_bib0039","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/phar.2478","article-title":"Drug-induced ototoxicity: a comprehensive review and reference guide","volume":"40","author":"Rizk","year":"2020","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.heares.2025.109262_bib0040","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/pds.1001","article-title":"The reporting odds ratio and its advantages over the proportional reporting ratio","volume":"13","author":"Rothman","year":"2004","journal-title":"Pharmacoepidemiol. Drug. Saf."},{"key":"10.1016\/j.heares.2025.109262_bib0041","first-page":"79","article-title":"Review of salicylate-induced hearing loss, neurotoxicity, tinnitus and neuropathophysiology","volume":"34","author":"Sheppard","year":"2014","journal-title":"Acta Otorhinolaryngol. Ital."},{"key":"10.1016\/j.heares.2025.109262_bib0042","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217951","article-title":"Analysis of drug-induced hearing loss by using a spontaneous reporting system database","volume":"14","author":"Tanaka","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.heares.2025.109262_bib0043","article-title":"Medical interventions for the prevention of platinum-induced hearing loss in children with cancer","volume":"9","author":"Van As","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.heares.2025.109262_bib0044","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1093\/jac\/dkab232","article-title":"Macrolide-associated ototoxicity: a cross-sectional and longitudinal study to assess the association of macrolide use with tinnitus and hearing loss","volume":"76","author":"Vanoverschelde","year":"2021","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.heares.2025.109262_bib0045","article-title":"Contrastive analysis on the safety of brand and generic nebivolol: a real-world pharmacovigilance study based on the Fda adverse event reporting system","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heares.2025.109262_bib0046","article-title":"Self-esteem in children and adolescents with hearing loss","volume":"19","author":"Warner-Czyz","year":"2015","journal-title":"Trends Hear"},{"key":"10.1016\/j.heares.2025.109262_bib0047","doi-asserted-by":"crossref","first-page":"9743","DOI":"10.1038\/s41598-024-60493-w","article-title":"Phosphodiesterase type 5 inhibitors related hearing impairment: a real world study based on the Fda adverse event reporting system","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci. Rep."}],"container-title":["Hearing Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378595525000814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378595525000814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T01:22:27Z","timestamp":1762305747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378595525000814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":47,"alternative-id":["S0378595525000814"],"URL":"https:\/\/doi.org\/10.1016\/j.heares.2025.109262","relation":{},"ISSN":["0378-5955"],"issn-type":[{"value":"0378-5955","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-induced hearing loss: a real-world pharmacovigilance study using the FDA adverse event reporting system database","name":"articletitle","label":"Article Title"},{"value":"Hearing Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heares.2025.109262","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109262"}}